Literature DB >> 30711347

Moraxella nonliquefaciens septic arthritis in a hematopoietic stem cell transplant patient a case report and review of the literature.

Mohamad Khalife1, Mira Merashli2, Souha S Kanj3.   

Abstract

BACKGROUND: Septic arthritis is a common rheumatologic condition with myriad microbiological causative agents. Moraxella is one of the very rare causes of septic arthritis. We hereby present the third case of Moraxella nonliquefaciens septic arthritis and the first case in a hematopoietic stem cell transplant patient (HSCT) along with a brief review of the literature.
METHODS: We used PubMed with google search engine to search the literature for reported cases of moraxella septic arthritis.
RESULTS: Information on 19 other cases of moraxella infectious arthritis was found. M. catarrhalis was the most common species isolated. Only 2 reports on M. nonliquefaciens were found; the first one in a multiple myeloma patient and the second one in a diabetic patient on hemodialysis. Predisposing conditions included inflammatory arthritis, prosthetic joints, diabetes, Human Immunodeficiency Virus (HIV) infection, Hepatitis C, hemodialysis, esophageal cancer, valve replacements, alcoholism and Intravenous (IV) drug use. The age group of the reported cases ranged from 3 months to 78 years.
CONCLUSION: Infectious arthritis with Moraxella spp. is a very rare entity which can occur in any age group and in the setting of various underlying medical conditions.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Hematopoietic stem cell transplant; Moraxella nonliquefaciens; Septic arthritis

Mesh:

Substances:

Year:  2019        PMID: 30711347     DOI: 10.1016/j.jiph.2019.01.059

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  1 in total

1.  Expression and pathogenesis of VCAM-1 and VLA-4 cytokines in multiple myeloma.

Authors:  Pan Hao; Chunli Zhang; Rongfu Wang; Ping Yan; Ruchen Peng
Journal:  Saudi J Biol Sci       Date:  2020-04-23       Impact factor: 4.219

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.